Publication | Closed Access

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Klean StudyTreatment And PreventionHiv InfectionClinical TrialsAntiviral Drug DevelopmentVirologyAntiviral TherapyPharmacotherapyAntiviral DrugHivMedicineRandomised Non-inferiority Trial